PET / CT

DLL3-Targeted PET/CT in Neuroendocrine Carcinoma

PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor

Evaluation of the Diagnostic Efficacy of a αvβ6/FAP-Targeting Heterodimeric Probe in Patients With Malignant Solid Tumors

Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinomar

Evaluation of [68Ga]DOTA-IR-780-C-4 in PET Imaging Studies for PSMA-Positive Prostate Cancer Patients

Study of Melanoma-Resistant PET Monitoring Based on Key Rate-limiting Enzymes for Fatty Acid Metabolism in Healthy Volunteers

Comparing 68Ga-CTR-FAPI and 18F-FDG PET/ CT in Cancer Detection

Breast Cancer PET/CT Imaging With 68Ga-pAKTi

The Prognostic Value of PET/CT for Tumor Progression in Patients With Metastatic Hormone-sensitive Prostate Cancer

68Ga-FAPI-46 in Staging of Pancreatic Adenocarcinoma

To Evaluate Transport Safety Between Different Scanning Methods for Patients in the Intensive Care Unit (ICU)

18F-FDG PET/TC in TIR3A E TIR3B

The Application Value of 68Ga-grazytracer PET in Immunotherapy for Stage III Non-small-cell Lung Cancer

68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.

Quantitative Analysis of PET/CT Images of Immune Related Side Effects in Metastatic Melanoma Patients

Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia

The Value of PET Quantitative Analysis of Coronary Physiology in Coronary Microvascular Disease

PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer